Skip to content

Altaviva System

by Medtronic Neuromodulation

PMA P240011

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P240011↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP240011 Date18 Sep 2025ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Full name
Altaviva
Trade Name
Medtronic Altaviva System
Generic Name
Stimulator, tibial, electrical, implantable, for urinary incontinence
PMA Number
FDA Product Code
QPT
Device Class
Class III
Advisory Committee
Gastroenterology, Urology
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Altaviva System is an implantable tibial electrical stimulator designed for neuromodulation therapy. Classified as a Stimulator, Tibial, Electrical, Implantable, for Urinary Incontinence, it delivers targeted electrical pulses to the tibial nerve to treat urge urinary incontinence (UUI) in patients unresponsive to or intolerant of conservative treatments. This device operates as a rechargeable, leadless neurostimulator, providing a minimally invasive alternative for long-term management of incontinence symptoms.

The system is implanted surgically and intended for single-patient use under sterile conditions. It is regulated under FDA_PMA (P240011) and falls under Device Class III, requiring strict adherence to implantable device standards. Storage and handling follow standard sterile medical device protocols, with no specific MRI safety restrictions noted. Authorized models include registration numbers 3018094310, 3010878085, 3005210579, 3010972758, 3004209178, 3003120897, 2182207, and 3013944123 as listed in the OpenFDA database.

Other devices from Medtronic Neuromodulation

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical purpose of the Altaviva System, and who is it intended for?

    The Altaviva System is designed as an implantable tibial nerve stimulator to treat **urge urinary incontinence (UUI)** in patients who have not responded to or cannot tolerate conservative treatments like behavioral therapy, medications, or pelvic floor exercises. It delivers targeted electrical pulses to the tibial nerve to help manage incontinence symptoms long-term.

  • How is the Altaviva System supplied, and what does this mean for clinical workflows?

    The Altaviva System is **single-patient use only**, meaning each device is intended for one patient and must be implanted under sterile conditions. This ensures patient-specific sterility and reduces cross-contamination risks, requiring proper sterile handling and surgical preparation protocols during implantation.

  • Are there specific models or registration numbers I should verify before ordering?

    Yes, the Altaviva System includes multiple authorized models with distinct registration numbers: **3018094310, 3010878085, 3005210579, 3010972758, 3004209178, 3003120897, 2182207, and 3013944123**. Always confirm the exact model and registration number against your inventory or ordering system to ensure compliance with regulatory requirements.

  • Does the Altaviva System have any special storage or handling requirements?

    Like all implantable devices, the Altaviva System must be stored and handled according to **standard sterile medical device protocols** to maintain integrity and safety. There are no specific MRI safety restrictions mentioned, but it should be stored in a clean, dry environment away from direct sunlight or extreme temperatures until use.

  • What regulatory pathway does the Altaviva System follow, and what does this mean for purchasing?

    The Altaviva System is approved under **FDA_PMA (P240011)**, a rigorous pathway for Class III devices, which includes implantable neurostimulators. This means it has undergone thorough clinical evaluation and is subject to strict post-market surveillance. Purchasers should ensure they are acquiring the device through authorized channels and verify the **PMA number (P240011)** and registration numbers to confirm authenticity and compliance.